Cargando…

Age-Dependent Association among Helicobacter pylori Infection, Serum Pepsinogen Levels and Immune Response of Children to Live Oral Cholera Vaccine CVD 103-HgR

BACKGROUND: Through its effects on gastric secretion, we hypothesized that Helicobacter pylori infection may influence oral immunization. Accordingly, we examined the association between H. pylori infection, serum pepsinogen (PG) (measures for H. pylori gastritis) and vibriocidal antibody (a correla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muhsen, Khitam, Lagos, Rosanna, Reymann, Mardi K., Graham, David Y., Pasetti, Marcela F., Levine, Myron M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893123/ https://www.ncbi.nlm.nih.gov/pubmed/24454714 http://dx.doi.org/10.1371/journal.pone.0083999

Ejemplares similares

Pre-existing Helicobacter pylori serum IgG enhances the vibriocidal antibody response to CVD 103-HgR live oral cholera vaccine in Malian adults
por: Muhsen, Khitam, et al.
Publicado: (2020)

CVD 103-HgR live, attenuated cholera vaccine strain viability in drinking waters from the US and Europe
por: Duffin, R. Paul, et al.
Publicado: (2021)

Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children and Adolescents Aged 6–17 Years
por: McCarty, James M., et al.
Publicado: (2020)

Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children Aged 2–5 Years in the United States
por: McCarty, James M., et al.
Publicado: (2021)

Long-Term Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Adolescents Aged 12–17 Years in the United States
por: McCarty, James M., et al.
Publicado: (2021)

Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator
por: Sow, Samba O., et al.
Publicado: (2017)

Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers
por: Islam, Kamrul, et al.
Publicado: (2018)

Sero-prevalence of Helicobacter pylori CagA immunoglobulin G antibody, serum pepsinogens and haemoglobin levels in adults
por: Muhsen, Khitam, et al.
Publicado: (2018)

Helicobacter pylori infection, serum pepsinogens as markers of atrophic gastritis, and leukocyte telomere length: a population-based study
por: Muhsen, Khitam, et al.
Publicado: (2019)

Helicobacter pylori Infection and Anemia
por: Muhsen, Khitam, et al.
Publicado: (2013)

Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection
por: Lee, Sun-Young
Publicado: (2016)

Long‐term Effect of Helicobacter pylori Infection on Serum Pepsinogens
por: Kikuchi, Shogo, et al.
Publicado: (2000)

Relationship Between Helicobacter pylori IgG Seroprevalence and the Immune Response to Poliovirus Vaccine Among School-Age Children From a Population With Near-Universal Immunity Level
por: Badran Abu Zher, Layaly, et al.
Publicado: (2022)

Helicobacter pylori antibody and pepsinogen testing for predicting gastric microbiome abundance
por: Choi, Saemi, et al.
Publicado: (2019)

Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection
por: Kikuchi, Shogo, et al.
Publicado: (2019)

A Systematic Review and Meta-analysis of the Association Between Giardia lamblia and Endemic Pediatric Diarrhea in Developing Countries
por: Muhsen, Khitam, et al.
Publicado: (2012)

Effect of Smoking on Serum Pepsinogen I Level Depends on Serological Status of Helicobacter pylori
por: Tatemichi, Masayuki, et al.
Publicado: (2001)

Serum Pepsinogen Values in Japanese Junior High School Students With Reference to Helicobacter Pylori Infection
por: Okuda, Masumi, et al.
Publicado: (2020)

Association of serum pepsinogens and gastrin-17 with Helicobacter pylori infection assessed by urea breath test
por: Zhou, Jun-peng, et al.
Publicado: (2022)

Differences in glycated hemoglobin levels and cholesterol levels in individuals with diabetes according to Helicobacter pylori infection
por: Haj, Saeda, et al.
Publicado: (2021)

An association between Helicobacter pylori infection and cognitive function in children at early school age: a community-based study
por: Muhsen, Khitam, et al.
Publicado: (2011)

Sex differences in urea breath test results for the diagnosis of Helicobacter pylori infection: a large cross-sectional study
por: Eisdorfer, Ido, et al.
Publicado: (2018)

Helicobacter Pylori Infection and Serum Pepsinogen I Concentration in Peptic Ulcer Patients: Effect of Bacterial Eradication
por: Park, Sill Moo, et al.
Publicado: (1996)

Helicobacter pylori Infection, Serum Pepsinogen Level and Gastric Cancer: A Case‐Control Study in Japan
por: Fukuda, Haruhiko, et al.
Publicado: (1995)

Associations of Helicobacter pylori infection and peptic disease with diabetic mellitus: Results from a large population-based study
por: Haj, Saeda, et al.
Publicado: (2017)

A survey of primary-care pediatricians regarding the management of Helicobacter pylori infection and celiac disease
por: Ben Tov, Amir, et al.
Publicado: (2019)

Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort
por: Abnet, C C, et al.
Publicado: (2011)

Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels
por: Eybpoosh, Sana, et al.
Publicado: (2015)

Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study
por: Leja, Marcis, et al.
Publicado: (2017)

Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer
por: De Re, Valli, et al.
Publicado: (2016)

A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication
por: Osumi, Hiroki, et al.
Publicado: (2017)

Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects
por: Yu, Hong, et al.
Publicado: (2021)

Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests
por: Hamashima, Chisato, et al.
Publicado: (2017)

Brand interchangeability of pepsinogen tests in the real-world setting after eradication of Helicobacter pylori: a community-based study
por: Chiang, Tsung-Hsien, et al.
Publicado: (2022)

HGR-ViT: Hand Gesture Recognition with Vision Transformer
por: Tan, Chun Keat, et al.
Publicado: (2023)

Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening
por: Chen, Xian-Zhe, et al.
Publicado: (2018)

Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens
por: Shimoyama, Tadashi, et al.
Publicado: (2017)

Prediction of true Helicobacter pylori-uninfected status using a combination of age, serum antibody and pepsinogen: Logistic regression analysis
por: Takayama, Takako, et al.
Publicado: (2020)

Serum Pepsinogen Values and Helicobacter pylori Status among Control Subjects of a Nested Case-Control Study in the JACC study
por: Kikuchi, Shogo, et al.
Publicado: (2005)

Epigenetics and Helicobacter pylori
por: Capparelli, Rosanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1adcmlutkuhhrb153gprl925et